Nervgen Pharma NGEN
NASDAQ NGEN
$1.50 -0.04 (-2.60%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Market Capitalization (2024 - 2026)

Updated

Nervgen Pharma (NGEN) reported Market Capitalization of $164.08 million for the quarter ended Jun 30, 2026, down 7.4% from $177.24 million a year earlier and down 45.4% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Market Capitalization (2024 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Nervgen Pharma posted Market Capitalization of $446.04 million, up 190.9% from the prior year.

  • By year, Market Capitalization came in at $153.33 million in the year ended Dec 31, 2024.
  • The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Market Capitalization since the quarter ended Mar 31, 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Nervgen Pharma 108.50 Mn 7.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 164.08 Mn
Mar 31, 2026 300.28 Mn
Dec 31, 2025 446.04 Mn
Jun 30, 2025 177.24 Mn
Mar 31, 2025 140.67 Mn
Dec 31, 2024 153.33 Mn
API Access

Nervgen Pharma Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=NGEN&period=max&api_key=YOUR_API_KEY